Pancreatic cancer what can I do to improve outcomes

Improving Your Pancreatic Cancer Outcomes: A Comprehensive Action Plan

I'm glad you're taking an active role in your care. Here's what the evidence shows can meaningfully improve outcomes for pancreatic cancer patients.

---

STEP 1: Get Comprehensive Genetic & Molecular Testing

This is the single most important step you can take right now.

Why Testing Matters

According to NCCN Guidelines and Dr. [removed] Strickler (Duke University), precision medicine is transforming pancreatic cancer treatment:

• In 2013: There were essentially NO targeted therapies for pancreatic cancer
• In 2024: We have FDA-approved treatments for specific mutations (BRCA, KRAS, PALB2, and others)
• Survival impact: Patients with targetable mutations who receive matched therapy can double their survival compared to standard chemotherapy alone

Two Types of Testing You Need

1. GERMLINE TESTING (Hereditary/Inherited Mutations)

• Tests your blood for inherited cancer predisposition genes
• Looks for: BRCA1, BRCA2, PALB2, Lynch syndrome, and others
• About 10% of pancreatic cancers have germline mutations
• Why it matters:
  • Opens access to PARP inhibitors (like olaparib) if you have BRCA mutations
  • Allows family members to get screening
  • Helps identify if you're eligible for clinical trials
• Cost: Often covered by insurance; ask your oncologist

2. SOMATIC/TUMOR MOLECULAR PROFILING (Your Cancer's Mutations)

• Tests the tumor itself (not your blood) for driver mutations
• Looks for: KRAS variants, BRCA mutations, BRAF, NTRK, MSI-H, TMB, and others
• Why it matters:
  • KRAS mutations (found in 87% of pancreatic cancers) now have targeted drugs in development
  • Other mutations may qualify you for immunotherapy or clinical trials
  • Helps your doctor choose the most effective chemotherapy

Action Steps

✅ Ask your oncologist: "Have you done molecular profiling on my tumor? Can I see the report?"

✅ Get it in writing: According to Dr. [removed], molecular profiling reports often live outside your medical chart. Print it out and carry it with you — especially important if you seek a second opinion.

✅ Recommended vendors: Foundation Medicine, Tempus, or similar comprehensive panels

---

STEP 2: Ensure You're Receiving Standard-of-Care Chemotherapy

First-Line Treatment Options

According to NCCN Guidelines and ASCO recommendations, the standard chemotherapy regimens are:

Option A: FOLFIRINOX (FFX)

• Combination of: 5-fluorouracil, leucovorin, irinotecan, oxaliplatin
• Best for: Fit patients (good performance status) with resectable or metastatic disease
• Survival: Median overall survival ~11 months for metastatic disease
• Side effects: More intense but manageable with supportive care

Option B: Gemcitabine + Nab-Paclitaxel (Gem/NabP, brand name Abraxane)

• Best for: Patients who can't tolerate FOLFIRINOX or have certain comorbidities
• Survival: Median overall survival ~8-9 months for metastatic disease
• Side effects: Generally better tolerated than FOLFIRINOX

Option C: Sequential Therapy (Emerging)

• Recent research shows FFX followed by Gem/NabP may improve outcomes compared to single-regimen chemotherapy
• This is being studied in clinical trials

Critical Question

✅ Ask your oncologist: "Which chemotherapy regimen are you recommending for me, and why? Am I a candidate for FOLFIRINOX?"

---

STEP 3: Consider Targeted Therapies Based on Your Mutations

If You Have BRCA1/BRCA2 Mutations

• PARP Inhibitors (like olaparib) are FDA-approved
• Important note: Germline BRCA mutations respond better to PARP inhibitors than somatic mutations
• Survival benefit: Being studied in ongoing trials

If You Have KRAS Mutations (87% of patients)

According to Dr. [removed] Strickler and recent ASCO data, this is where precision medicine is advancing rapidly:

• Sotorasib (Lumakras) — FDA-approved for KRAS G12C mutations
• Adagrasib (Krazati) — FDA-approved for KRAS G12C mutations
• New combinations: KRAS inhibitors + chemotherapy + immunotherapy being tested
• Dr. [removed] quote: "I'm particularly optimistic about our new approaches to target KRAS, which could open up a whole range of new therapies for patients with pancreas cancer outside of traditional cytotoxic chemotherapy."

If You Have Other Mutations

• MSI-H (Microsatellite Instability): Immunotherapy may be beneficial
• NTRK fusions: Targeted therapies available
• BRCA-like mutations: PARP inhibitors may help

✅ Action: Once you have molecular profiling results, ask: "Based on my specific mutations, what targeted therapies should I consider?"

---

STEP 4: Explore Clinical Trials

Clinical trials often offer access to cutting-edge treatments before they become standard care.

Types of Trials to Consider

Immunotherapy Combinations:

• Anti-CD40 antibodies + chemotherapy
• PD-1 inhibitors + chemotherapy
• GVAX (pancreatic cancer vaccine) + checkpoint inhibitors

Novel Drug Combinations:

• KRAS inhibitors + MEK inhibitors
• Chemotherapy + canakinumab (anti-inflammatory)
• SBRT (radiation) + immunotherapy

Personalized Approaches:

• Neoantigen vaccines (personalized to your tumor)
• Ketogenic diet + chemotherapy (early Phase II data shows promise)

Where to Find Trials

• ClinicalTrials.gov — search "pancreatic cancer"
• Let's Win Pancreatic Cancer Trial Finder — curated pancreatic cancer trials
• Your oncologist — ask directly about trials at their institution
• Cancer Commons — personalized trial matching service

✅ Action: Ask your oncologist: "Are there any clinical trials I'm eligible for? Can you help me explore options?"

---

STEP 5: Optimize Supportive Care (Often Overlooked!)

Research shows that how well you tolerate treatment directly impacts survival. Patients who maintain weight and complete scheduled doses have better outcomes.

Nutrition & Pancreatic Enzymes

According to Let's Win Pancreatic Cancer and MD Anderson experts:

• About 1/3 of pancreatic cancer patients have pancreatic enzyme insufficiency (can't digest food properly)
• Symptoms: Greasy stools, excessive gas, bloating, weight loss, diarrhea
• Solution: Pancreatic enzyme replacement therapy (prescription enzymes taken with meals)
• Work with a dietitian: Ideally one with oncology certification (CSO credential) and experience with pancreatic cancer

Nutrition Guidelines:

• Eat 6-8 small, frequent meals daily (don't rely on hunger cues)
• Limit high-fat foods (your pancreas can't handle them)
• Avoid high-sugar foods (pancreatic cancer affects blood sugar regulation)
• Stay hydrated: Aim for half your body weight in ounces of water daily
• Keep a food diary: Track what you eat, bowel movements, and how you feel

Exercise

According to NCCN Guidelines and research, exercise before, during, and after treatment:

• Improves treatment tolerance
• Reduces fatigue and anxiety
• Stimulates appetite
• Associated with better outcomes
• Even 5-15 minutes, 2-3 times daily helps

✅ Action: Ask for a referral to an oncology dietitian and physical therapist

Manage Side Effects Proactively

• Nausea: Anti-nausea medications, ginger, small frequent meals
• Fatigue: Exercise, adequate